(Total Views: 148)
Posted On: 05/05/2020 12:30:09 PM
Post# of 44029

$TSOI COVID19 drug news Therapeutic Solutions International Leverages Filed and Issued Intellectual Property to Develop COVID-19 Nutraceutical Candidate: QuadraMune™
Company Intends to Initiate Clinical Trials using Novel "Multipronged" Attack on Coronavirus Pathology
https://www.prnewswire.com/news-releases/ther...52960.html
Company Intends to Initiate Clinical Trials using Novel "Multipronged" Attack on Coronavirus Pathology
https://www.prnewswire.com/news-releases/ther...52960.html

